Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.3100 (2.4%) ($30.0100 - $31.1000) on Wed. Dec. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.14% (three month average) | RSI | 70 | Latest Price | $30.3100(2.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(61%) XBI(60%) IWO(59%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.07% in a week (0% probabilities). VXX(-13%) VIXM(-10%) GDXJ(-6%) TLT(-5%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.07% (StdDev 4.14%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $29.4(3.1%) | 10 Day Moving Average | $29.97(1.13%) | 20 Day Moving Average | $28.94(4.73%) | To recent high | -8.7% | To recent low | 24.3% | Market Cap | $1.882b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |